Public Profile

Kubota Pharmaceutical Holdings Co., Ltd.

Kubota Pharmaceutical Holdings Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in Japan (JP) and operates extensively across Asia and beyond. Founded in 2014, the company has rapidly established itself as a leader in the development of innovative therapies, particularly in the fields of oncology and rare diseases. Kubota Pharmaceutical is renowned for its unique approach to drug development, focusing on precision medicine and advanced biopharmaceuticals. Its core products aim to address unmet medical needs, setting the company apart in a competitive market. With a commitment to research and development, Kubota has achieved significant milestones, including strategic partnerships and successful clinical trials, reinforcing its position as a forward-thinking entity in the pharmaceutical landscape.

DitchCarbon Score

How does Kubota Pharmaceutical Holdings Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

13

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

Kubota Pharmaceutical Holdings Co., Ltd.'s score of 13 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

58%

Kubota Pharmaceutical Holdings Co., Ltd.'s reported carbon emissions

Kubota Pharmaceutical Holdings Co., Ltd., headquartered in Japan (JP), currently does not have available carbon emissions data or specific reduction targets. As a result, there are no reported figures for their Scope 1, 2, or 3 emissions. The company has not outlined any formal climate commitments or initiatives aimed at reducing carbon emissions. In the context of the pharmaceutical industry, it is increasingly important for companies to establish clear climate strategies and targets to address environmental impacts. Without specific data or commitments, it remains unclear how Kubota Pharmaceutical is approaching climate change and sustainability.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Kubota Pharmaceutical Holdings Co., Ltd.'s primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Kubota Pharmaceutical Holdings Co., Ltd. is headquartered in JP, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Kubota Pharmaceutical Holdings Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Cardax, Inc.

US
Chemicals nec
Updated 6 days ago

Glaxosmithkline

GB
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Amarin Corporation plc

IE
Chemicals nec
Updated 6 days ago

Astellas

JP
Medical, precision and optical instruments, watches and clocks (33)
Updated 6 days ago

Astra Zeneca

GB
Chemicals nec
Updated 36 minutes ago

Johnson And Johnson

US
Chemicals nec
Updated 6 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers